Concepedia

Author

Casey Cunningham

Texas Oncology

Also Known As

C C Cunningham, C Casey Cunningham, C Cunningham, C. C. Cunningham, C. Casey Cunningham, C. Cunningham, C.C. Cunningham, C.Casey Cunningham, Cameron Cunningham, Casey C. Cunningham

110

Publications

5.4K

Citations

35

H-Index

72

Concepts

All Affiliations

Texas OncologyBaylor University Medical CenterMary Crowley Cancer Research CenterBrigham and Women's HospitalHarvard University
CC

About

Casey Cunningham is an author at Texas Oncology specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

17

2.5K

2

Natural Sciences

3

3

496

3

Engineering

2

2

888

4

Biochemistry

2

2

227

5

Health Sciences

1

1

332

Casey Cunningham

×

43

Publications

5K

Citations

34

H-Index

YearCitations

Actin-Binding Protein Requirement for Cortical Stability and Efficient Locomotion

Casey Cunningham, Jed B. Gorlin, David J. Kwiatkowski,

Science

1992

569

Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer

John Nemunaitis, Robert O. Dillman, Paul Schwarzenberger,

Journal of Clinical Oncology

2006

358

Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients

John Nemunaitis, Casey Cunningham, Neil Senzer,

Cancer Gene Therapy

2003

332

Enhanced Motility in NIH 3T3 Fibroblasts That Overexpress Gelsolin

Casey Cunningham, Thomas P. Stossel, David J. Kwiatkowski

Science

1991

319

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

John Nemunaitis, Casey Cunningham, A Buchanan,

Gene Therapy

2001

280

Actin polymerization and intracellular solvent flow in cell surface blebbing.

Casey Cunningham

The Journal of Cell Biology

1995

269

Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study

Casey Cunningham, Sunil Chada, James A. Merritt,

Molecular Therapy

2004

207

Intratumoral Injection of INGN 241, a Nonreplicating Adenovector Expressing the Melanoma-Differentiation Associated Gene-7 (mda-7/IL24): Biologic Outcome in Advanced Cancer Patients

Alex W. Tong, John Nemunaitis, Dan Su,

Molecular Therapy

2004

198

TNFerade Biologic, an Adenovector With a Radiation-Inducible Promoter, Carrying the Human Tumor Necrosis Factor Alpha Gene: A Phase I Study in Patients With Solid Tumors

Neil Senzer, Sridhar Mani, Alexander S. Rosemurgy,

Journal of Clinical Oncology

2004

196

Actin-biding Protein-280 Binds the Stress-activated Protein Kinase (SAPK) Activator SEK-1 and Is Required for Tumor Necrosis Factor-α Activation of SAPK in Melanoma Cells

Amelia Martí, Zhijun Luo, Casey Cunningham,

Journal of Biological Chemistry

1997

167

Page 1